Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ajog.2010.06.014PMID 20691410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach

  2010cited by this paper
• Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks

  2010cited by this paper
• Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia

  2009cited by this paper
• Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.

  2009cited by this paper
• First-trimester prediction of early preeclampsia: a possibility at last!

  2009cited by this paper
• First-Trimester Prediction of Hypertensive Disorders in Pregnancy

  2009cited by this paper
• Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy

  2009cited by this paper
• First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia

  2009cited by this paper
• Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks

  2009cited by this paper
• Tests to Predict Preeclampsia

  2009cited by this paper
• Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks

  2009cited by this paper
• Chesley's Hypertensive Disorders in Pregnancy

  2009cited by this paper
• A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

  2008cited by this paper
• Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre‐eclampsia

  2008cited by this paper
• Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre‐eclampsia

  2008cited by this paper
• First‐trimester uterine artery Doppler indices in term and preterm pre‐eclampsia

  2008cited by this paper
• Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis

  2008cited by this paper
• The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

  2008cited by this paper
• Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

  2007cited by this paper
• First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia

  2007cited by this paper
• An integrated model for the prediction of pre-eclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.

  2006cited by this paper
• Viral particles in endomyocardial biopsy tissue from peripartum cardiomyopathy patients.

  2006cited by this paper
• Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population

  2005cited by this paper
• Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

  2005cited by this paper
• An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.

  2005cited by this paper
• A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound

  2005cited by this paper
• Reduction of the Disintegrin and Metalloprotease ADAM12 in Preeclampsia

  2005cited by this paper
• Screening for pre-eclampsia: the quest for the Holy Grail?

  2005cited by this paper
• Pre-eclampsia

  2005cited by this paper
• World Health Organization Systematic Review of Screening Tests for Preeclampsia

  2004cited by this paper
• First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

  2004cited by this paper
• The role of uterine artery Doppler in predicting adverse pregnancy outcome.

  2004cited by this paper
• First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

  2004cited by this paper
• Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies.

  2004cited by this paper
• First‐trimester uterine artery blood flow and birth weight

  2003cited by this paper
• Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.

  2003cited by this paper
• Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

  2002cited by this paper
• Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcome

  2002cited by this paper
• The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

  2001cited by this paper
• The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

  2001cited by this paper
• Pre-eclampsia

  2000cited by this paper
• First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications

  2000cited by this paper

• Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study.

  2026cites this paper
• A comprehensive first-trimester predictive model for preeclampsia based on multi-indicators and machine learning: A retrospective single-center study

  2025cites this paper
• Minimum test tradeoff applied to uterine artery pulsatility index for antepartum prediction of preeclampsia.

  2025cites this paper
• Maternal Uterine Artery Doppler and Serum Marker in the First Trimester as Predictive Markers for Small for Gestational Age Neonates and Preeclampsia: A Pilot Study

  2025cites this paper
• Pregnancy-associated plasma protein A (PAPP-A) as a first trimester serum biomarker for preeclampsia screening: a systematic review and meta-analysis

  2025cites this paper
• Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia: A validation study.

  2025cites this paper
• First‐Trimester Prediction Models Based on Maternal Characteristics for Adverse Pregnancy Outcomes: A Systematic Review and Meta‐Analysis

  2024cites this paper
• Routine ante-natal screening using maternal risk factors and biomarkers for preeclampsia in 11-13+6 weeks of gestation

  2024cites this paper
• Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.

  2024cites this paper
• Vlera prediktive e dopplerit tё arterieve uterine nё tremujorin e parё pёr preeklampsinё

  2024cites this paper
• Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study

  2024cites this paper
• A rapid diagnostic technique based on metabolomics to differentiate between preeclampsia (PE) and chronic kidney disease (CKD) using maternal urine

  2024cites this paper
• Externally validated prediction models for pre‐eclampsia: systematic review and meta‐analysis

  2023cites this paper
• A mathematical model of vascular and hemodynamics changes in early and late forms of preeclampsia

  2023influential citation
• Prediction of preeclampsia in asymptomatic women.

  2023cites this paper
• Higher PAPP-A Values in Pregnant Women Complicated with Preeclampsia Than with Gestational Hypertension

  2023cites this paper
• The association between hCG and adverse pregnancy outcomes: a systematic review and meta-analysis.

  2023cites this paper
• Comparative evaluation of gestosis score vs uterine artery pulsatility index in predicting gestational hypertension: A study protocol

  2023cites this paper
• In�uence of anti-coagulant therapy in the �rst trimester uterine �ow indices

  2023cites this paper
• Clinical Application of a Graphene Oxide-Based Surface Plasmon Resonance Biosensor to Measure First-Trimester Serum Pregnancy-Associated Plasma Protein-A/A2 Ratio to Predict Preeclampsia

  2023influential citation
• Umbilical artery half peak systolic velocity deceleration time: a novel Doppler parameter for prediction of neonatal outcomes in pregnant women with preeclampsia

  2023cites this paper
• Pregnancy Induced Hypertensive Disorders among Patients Admitted to the Department of Obstetric and Gynecology in a Tertiary Care Centre: A Descriptive Cross-sectional Study

  2023cites this paper
• The significance of mitochondrial haplogroups in preeclampsia risk.

  2023cites this paper
• Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes

  2023cites this paper
• Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies.

  2022cites this paper
• Risk Factors and Predictors for Pre-eclampsia

  2022cites this paper
• A mathematical model of maternal vascular growth and remodeling and changes in maternal hemodynamics in uncomplicated pregnancy

  2022cites this paper
• Preventing Pre-eclampsia and its Complications

  2022cites this paper
• Early prediction and longitudinal modeling of preeclampsia from multiomics

  2022cites this paper
• Evaluation of First Trimester Uterine Artery Doppler, Placental Growth Factor and Maternal Characteristics in Prediction of Preeclampsia

  2022cites this paper
• Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women

  2022cites this paper
• Serum levels of LDH and protein/creatinine index in pregnant women with preeclampsia: A single-center retrospective study

  2022cites this paper
• Multiomics Longitudinal Modeling of Preeclamptic Pregnancies

  2021cites this paper
• Title: Multiomics Longitudinal Modeling of Preeclamptic Pregnancies

  2021cites this paper
• Smoking for two- effects of tobacco consumption on placenta.

  2021cites this paper
• Pregnancy hypertension: An international journal of women's cardiovascular health.

  2021cites this paper
• COMBINED FIRST TRIMESTER MATERNAL PLATELETS INDICES AND UTERINE ARTERY DOPPLER IN PREDICTION OF PRE-ECLAMPSIA IN PRIMIGRAVIDAE

  2021cites this paper
• Fetal structural and genetic anomaly screening. Are we doing it correct at the age of NIPT?

  2021cites this paper
• Combination of three‐dimensional placental vascular indices and volume and uterine artery pulsatility index at 10–13 weeks of gestation could improve the prediction of adverse pregnancy outcomes

  2021cites this paper
• Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.

  2020cites this paper
• First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study.

  2020cites this paper
• PAPP‐A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia

  2020cites this paper
• Early prediction of preeclampsia via machine learning.

  2020cites this paper
• Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study

  2020cites this paper
• Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia

  2020cites this paper
• Sleep Disordered Breathing, a Novel, Modifiable Risk Factor for Hypertensive Disorders of Pregnancy

  2020cites this paper
• First trimester preeclampsia screening and prediction.

  2020cites this paper
• Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use

  2020cites this paper
• Risk factors for hypertensive disorders of pregnancy in Abuja, Nigeria: A prospective case-control study

  2020cites this paper
• Screening and prevention of pre-eclampsia: a review

  2019cites this paper
• Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study

  2019cites this paper
• External validation of the Fetal Medicine Foundation algorithm for the prediction of preeclampsia in a Brazilian population.

  2019cites this paper
• The prediction of early preeclampsia: Results from a longitudinal proteomics study

  2019cites this paper
• Schwangerschaften nach assistierter Reproduktion

  2019cites this paper
• How do maternal factors impact preeclampsia prediction in Brazilian population?

  2019cites this paper
• FEATURES OF PREGNANCY IN NULLIPAROUS WITH EARLY PREECLAMPSIA

  2019cites this paper
• Prediction models for preeclampsia: A systematic review.

  2019cites this paper
• Modern methods of great obstetrical syndromes prognostication (literature review).

  2019cites this paper
• Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia

  2019influential citation
• Association entre la thérapie antirétrovirale et les biomarqueurs de la fonction placentaire pendant la grossesse

  2019cites this paper
• Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome

  2019influential citation
• Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Cardiac diastolic function after recovery from pre-eclampsia

  2018cites this paper
• Preeclampsia biomarkers: An assessment of maternal cardiometabolic health.

  2018cites this paper
• Maternal and Perinatal Outcome Associated With Gestational Hypertension

  2018cites this paper
• First-Trimester Uterine Artery Doppler for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndrome Study

  2018cites this paper
• Ther External Validation and Clinical Usefulness of First Trimester Prediction Models for the Risk of Preeclampsia : A Prospective Cohort Study

  2018cites this paper
• Role of Laeverin in the pathophysiology of preeclampsia

  2018cites this paper
• External Validation and Clinical Usefulness of First Trimester Prediction Models for the Risk of Preeclampsia: A Prospective Cohort Study

  2018cites this paper
• First-Trimester Placental Growth Factor for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes Cohort Study

  2018cites this paper
• Prediction and prevention of pre‐eclampsia in Asian subpopulation

  2018cites this paper
• Prediction of pre-eclampsia in early pregnancy using PAPP-A and uterine artery pulsatility index

  2018cites this paper
• Original Research

  2018cites this paper
• Changes in maternal placental growth factor levels during term labour.

  2018cites this paper
• Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits

  2018cites this paper
• Sleep disordered breathing in pregnant women: maternal and fetal risk, treatment considerations, and future perspectives

  2018cites this paper
• The Use of Biochemical and Biophysical Markers in Early Screening for Preeclampsia in Mongolia

  2018cites this paper
• Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory

  2018cites this paper
• Personalizing obstetric care: prediction and prevention of adverse pregnancy outcomes

  2018cites this paper
• Mining DNA methylation alterations towards a classification of placental pathologies

  2017cites this paper
• Is Canada Ready to Adopt Maternal Placental Growth Factor Testing to Improve Clinical Outcomes for Women with Suspected Preeclampsia?

  2017cites this paper
• Use of first‐trimester placenta growth factor concentration to predict hypertensive disorders of pregnancy in a low‐risk Asian population

  2017cites this paper
• First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population

  2017cites this paper
• Maternal & Perinatal outcome in Hypertensive Disorders of Pregnancy in a Tertiary Care Hospital in Northern India

  2017cites this paper
• Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model

  2017cites this paper
• Präeklampsie: Screening und Management

  2017cites this paper
• The value of DNA methylation profiling in characterizing preeclampsia and intrauterine growth restriction

  2017cites this paper
• Genetic and epigenetic profiling of placental insufficiency : identifying biomarkers of preeclampsia and intrauterine growth restriction

  2017cites this paper
• Instrucciones a los Autores

  2017influential citation
• Does Low PAPP-A Predict Adverse Placenta-Mediated Outcomes in a Low-Risk Nulliparous Population? the Great Obstetrical Syndromes (GOS) Study.

  2017cites this paper
• PREDICTORS FOR ADVERSE MATERNAL AND FETAL OUTCOMES IN HIGH RISK PREGNANCY

  2017cites this paper
• Uterine artery Doppler: Changing Concepts in Prediction and Prevention of PE and FGR

  2017cites this paper
• Early predictors of preterm labor and preeclampsia: a prospective study

  2017cites this paper
• First-trimester placental thickness and the risk of preeclampsia or SGA.

  2017cites this paper
• Facteurs prédictifs et pronostiques de la prééclampsie : intérêt du dosage du PlGF et du sFLT-1

  2016cites this paper
• Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction.

  2016cites this paper
• A standardized approach for the assessment of the lower uterine segment at first trimester by transvaginal ultrasound: a flash study

  2016cites this paper
• Optimal first trimester preeclampsia prediction: a comparison of multimarker algorithm, risk profiles and their sequential application

  2016cites this paper
• First and second trimester maternal serum inhibin A levels in twins with pre‐eclampsia

  2016cites this paper
• Prognostic models in obstetrics: available, but far from applicable.

  2016cites this paper